We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Key Molecule for Flu Infection, a Novel Target for Drug Development?

News   May 31, 2018 | Original story from Hokkaido University

 
Key Molecule for Flu Infection, a Novel Target for Drug Development?

Human bronchial epithelial cells cultured with (right) or without (left) a calcium channel blocker (CCB) prior to exposure to IAV. Red signals show infected and replicated IAV. Treatment with CCB significantly suppressed IAV infections. Credit: Fujioka Y. et al., Cell Host & Microbe, May 17, 2018

 
 
 

RELATED ARTICLES

3D Tracking How a Virus Moves Through a Mosquito

News

Researchers hope to one day inhibit the genes involved with the release of the virus from within the mosquito’s stomach to prevent future transmission of mosquito-borne diseases.

READ MORE

Blood Test May Enable Tailored Cystic Fibrosis Treatment

News

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

READ MORE

Loss of Tight Junction Protein Promotes Development of Precancerous Cells

News

Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE